Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

CD33-specific CAR lentiviral vector-transduced allogeneic T lymphocytes

A preparation of allogeneic T lymphocytes transduced with a lentiviral vector expressing a chimeric antigen receptor (CAR) specific for the CD33 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, CD33-specific CAR lentiviral vector-transduced allogeneic T lymphocytes target and induce selective toxicity in CD33-expressing tumor cells. CD33 is expressed on normal non-pluripotent hematopoietic stem cells and on myeloid leukemia cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic anti-CD33 chimeric antigen receptor T cells allogeneic CD33-CAR-T cells allogneic anti-CD33 CAR-T cells

CD33-specific CAR lentiviral vector-transduced allogeneic T lymphocytes

Search NCI's Drug Dictionary